Catalyst Wire Dossier Catalyst Wire Dossier

Vyleesi

Bremelanotide · Palatin Technologies, Inc
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Vyleesi, covering 2019-06-21 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk [Phase 4]

See pricing